How tumors evade immunotherapy: DDB1 sends PD-L1 into nuclei, driving anti-PD-1 resistance
Immune checkpoint blockade has reshaped modern oncology, but its success remains uneven. Drugs that disrupt the PD-1/PD-L1 pathway can produce ...
Tag: biomarkers for immunotherapy response
Myeloid Cell Signaling Identified as Key Driver of Immunotherapy Resistance in Kidney Cancer
In a groundbreaking revelation poised to redefine therapeutic strategies for advanced renal cell carcinoma (RCC), researchers at Dana-Farber Cancer Institute ...
Predictors of Immune Therapy Success in Ovarian Cancer
In the complex landscape of oncology, researchers are continuously investigating innovative treatment options for patients facing challenging diagnoses, particularly in ...
Advancing Tumor Immunotherapy: The Role of Spatial and Single-Cell Omics in Biomarker Discovery
Tumor immunotherapy has revolutionized the landscape of cancer treatment by leveraging the immune system to effectively recognize and eliminate malignant ...
CHEK2 Emerges as a Promising Target to Enhance Immunotherapy in Solid Tumors
In recent years, the landscape of cancer treatment has been dramatically transformed by the advent of immune checkpoint inhibitors (ICIs), ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!